piracetam has been researched along with Trigeminal Neuralgia in 2 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
Trigeminal Neuralgia: A syndrome characterized by recurrent episodes of excruciating pain lasting several seconds or longer in the sensory distribution of the TRIGEMINAL NERVE. Pain may be initiated by stimulation of trigger points on the face, lips, or gums or by movement of facial muscles or chewing. Associated conditions include MULTIPLE SCLEROSIS, vascular anomalies, ANEURYSMS, and neoplasms. (Adams et al., Principles of Neurology, 6th ed, p187)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to determine whether levetiracetam (LEV) is an effective drug for treatment of trigeminal neuralgia (TN)." | 9.14 | Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. ( Johnston, A; Jorns, TP; Zakrzewska, JM, 2009) |
| "To explore the efficacy and tolerability of levetiracetam in medical treatment of trigeminal neuralgia." | 9.14 | An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia. ( Avramidis, TG; Fili, VA; Gatzonis, SD; Karageorgiou, KE; Mitsikostas, DD; Pantes, GV; Siatouni, AD; Stathis, PG; Vikelis, M, 2010) |
| "The objective of this study was to determine whether levetiracetam (LEV) is an effective drug for treatment of trigeminal neuralgia (TN)." | 5.14 | Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia. ( Johnston, A; Jorns, TP; Zakrzewska, JM, 2009) |
| "To explore the efficacy and tolerability of levetiracetam in medical treatment of trigeminal neuralgia." | 5.14 | An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia. ( Avramidis, TG; Fili, VA; Gatzonis, SD; Karageorgiou, KE; Mitsikostas, DD; Pantes, GV; Siatouni, AD; Stathis, PG; Vikelis, M, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jorns, TP | 1 |
| Johnston, A | 1 |
| Zakrzewska, JM | 1 |
| Mitsikostas, DD | 1 |
| Pantes, GV | 1 |
| Avramidis, TG | 1 |
| Karageorgiou, KE | 1 |
| Gatzonis, SD | 1 |
| Stathis, PG | 1 |
| Fili, VA | 1 |
| Siatouni, AD | 1 |
| Vikelis, M | 1 |
2 trials available for piracetam and Trigeminal Neuralgia
| Article | Year |
|---|---|
Pilot study to evaluate the efficacy and tolerability of levetiracetam (Keppra) in treatment of patients with trigeminal neuralgia.
Topics: Aged; Aged, 80 and over; Anticonvulsants; Dose-Response Relationship, Drug; Drug Administration Sche | 2009 |
An observational trial to investigate the efficacy and tolerability of levetiracetam in trigeminal neuralgia.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Female; Humans; Levetiracetam; Male; Middle Aged; Pilot Pr | 2010 |